New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

A new study shows that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

B-cells protect your body from infection. But sometimes, they misfire and cause debilitating disease. Now, University of ...

Under terms of the deal, AbbVie will acquire Capstan’s lead asset, CPTX2309—an in vivo anti-CD19 CAR T-cell therapy in Phase ...

Cue applied technology it initially tested in the treatment of cancers to the development of CUE-501. The idea is to make B cells appear as if they are infected with a virus such as ...

The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...

T-cell/histiocyte-rich B-cell lymphoma: A form of DLBCL that has the following characteristics when viewed under a microscope: a few scattered large and atypical B cells; ...